Literature DB >> 8600510

Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay.

M C Kavanagh1, A Sun, Q Hu, R P Hill.   

Abstract

Using five transplantable murine tumors (SCC-VII, B16F1, KHT-C, KHT-LP1, RIF-1), measurements of tumor hypoxia have been made with two techniques which have the potential to be used for assessing oxygenation in human tumors (the Eppendorf pO2 Histograph and binding of [3H]misonidazole) and have been compared with an established radiobiological technique, the paired survival assay. There were significant differences in the pO2 measurements made in individual tumors both within and between the five different tumor types. Significant differences between the tumor types were also found for the [3H]misonidazole binding. A correlation was observed between the mean values of the hypoxic proportion as measured by the paired survival assay and the mean binding of [3H]misonidazole as measured by both tumor activity in dpm/100 mg tissue (r = 0.94, P = 0.02) and the tumor-to-muscle activity ratio (r = 0.87, P = 0.06). No biologically significant correlation was seen between the mean values of the hypoxic proportion from anesthetized mice as measured by the paired survival assay (range 20-58%) and the pooled Eppendorf pO2 Histograph measurements made on groups of tumors. These results with the Eppendorf pO2 Histograph are similar to those reported by others. When both Eppendorf pO2 Histograph measurements and paired survival measurements were made on the same individual KHT-C tumors, it was again found that there was no correlation between the two measurements of hypoxia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600510

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  13 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.

Authors:  E O Aboagye; R J Maxwell; M R Horsman; A D Lewis; P Workman; M Tracy; J R Griffiths
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  In vivo imaging of changes in tumor oxygenation during growth and after treatment.

Authors:  Anna Bratasz; Ramasamy P Pandian; Yuanmu Deng; Sergey Petryakov; John C Grecula; Nilendu Gupta; Periannan Kuppusamy
Journal:  Magn Reson Med       Date:  2007-05       Impact factor: 4.668

4.  A comparative evaluation of EPR and OxyLite oximetry using a random sampling of pO(2) in a murine tumor.

Authors:  Deepti S Vikram; Anna Bratasz; Rizwan Ahmad; Periannan Kuppusamy
Journal:  Radiat Res       Date:  2007-09       Impact factor: 2.841

Review 5.  Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

6.  (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.

Authors:  Takuya Toyonaga; Kenji Hirata; Shigeru Yamaguchi; Kanako C Hatanaka; Sayaka Yuzawa; Osamu Manabe; Kentaro Kobayashi; Shiro Watanabe; Tohru Shiga; Shunsuke Terasaka; Hiroyuki Kobayashi; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-03       Impact factor: 9.236

7.  Modeling the spatial distribution of chronic tumor hypoxia: implications for experimental and clinical studies.

Authors:  Gibin Powathil; Mohammad Kohandel; Michael Milosevic; Siv Sivaloganathan
Journal:  Comput Math Methods Med       Date:  2012-01-29       Impact factor: 2.238

8.  Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay.

Authors:  P L Olive; M R Horsman; C Grau; J Overgaard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response.

Authors:  Keith A Cengel; Amit Maity; Theresa M Busch; Anastasia Velalopoulou; Ilias V Karagounis; Gwendolyn M Cramer; Michele M Kim; Giorgos Skoufos; Denisa Goia; Sarah Hagan; Ioannis I Verginadis; Khayrullo Shoniyozov; June Chiango; Michelle Cerullo; Kelley Varner; Lutian Yao; Ling Qin; Artemis G Hatzigeorgiou; Andy J Minn; Mary Putt; Matthew Lanza; Charles-Antoine Assenmacher; Enrico Radaelli; Jennifer Huck; Eric Diffenderfer; Lei Dong; James Metz; Constantinos Koumenis
Journal:  Cancer Res       Date:  2021-07-28       Impact factor: 13.312

10.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.

Authors:  T M Sitnik; J A Hampton; B W Henderson
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.